SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+18.01%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.51B
AUM Growth
+$1.51B
(+2.7%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
65.29%
Holding
64
New
13
Increased
8
Reduced
13
Closed
14
Top Buys
| 1 |
AstraZeneca
AZN
|
$121M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$51.1M |
| 3 |
Idexx Laboratories
IDXX
|
$35.5M |
| 4 |
Exelixis
EXEL
|
$33.1M |
| 5 |
Boston Scientific
BSX
|
$32.9M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$85M |
| 2 |
Eli Lilly
LLY
|
$47.1M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$44.6M |
| 4 |
Biogen
BIIB
|
$36.9M |
| 5 |
Merck
MRK
|
$36.2M |
Sector Composition
| 1 | Healthcare | 99.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Y-mAbs Therapeutics
YMAB
$390M
| $14.9M | 0.98% |
2,194,278
| – | – |
|
27
Revolution Medicines
RVMD
$7.43B
| $13.9M | 0.91% |
520,377
+336,539
| +183% | +$9M |
|
28
Axsome Therapeutics
AXSM
$6.09B
| $12.9M | 0.84% |
179,242
+58,346
| +48% | +$4.19M |
|
29
Vir Biotechnology
VIR
$765M
| $12M | 0.78% |
488,117
-169,442
| -26% | -$4.16M |
|
30
PTC Therapeutics
PTCT
$4.41B
| $10.6M | 0.69% |
260,443
-256,652
| -50% | -$10.4M |
|
|
MRNS
31
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.5M | 0.68% |
962,619
-237,770
| -20% | -$2.58M |
|
|
GRTX
32
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $9.62M | 0.63% |
3,083,712
| – | – |
|
33
Replimune Group
REPL
$460M
| $8.1M | 0.53% |
+348,889
| New | +$8.1M |
|
|
AGEN
34
Agenus
AGEN
$136M
| $7.85M | 0.51% |
4,909,132
-1,498,325
| -23% | -$2.59M |
|
35
Celldex Therapeutics
CLDX
$1.57B
| $6.71M | 0.44% |
197,758
-221,639
| -53% | -$7.52M |
|
36
Dyne Therapeutics
DYN
$1.92B
| $4.96M | 0.33% |
+441,048
| New | +$4.96M |
|
37
NextCure
NXTC
$13.3M
| $4.81M | 0.32% |
2,671,856
| – | – |
|
|
NCNA
38
NuCana
NCNA
$5.8M
| $4.42M | 0.29% |
5,599,999
| – | – |
|
39
Bolt Biotherapeutics
BOLT
$9.29M
| $3.53M | 0.23% |
2,754,437
| – | – |
|
40
FibroGen
FGEN
$48.4M
| $1.72M | 0.11% |
+637,567
| New | +$1.72M |
|
41
PDS Biotechnology
PDSB
$60.6M
| $717K | 0.05% |
142,635
| – | – |
|
|
FUSN
42
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $547K | 0.04% |
117,099
| – | – |
|
43
Savara
SVRA
$591M
| $308K | 0.02% |
+96,248
| New | +$308K |
|
|
ALLK
44
DELISTED
Allakos
ALLK
| $272K | 0.02% |
+62,465
| New | +$272K |
|
45
Synlogic
SYBX
$17.4M
| $247K | 0.02% |
574,972
| – | – |
|
46
Mirum Pharmaceuticals
MIRM
$3.75B
| $235K | 0.02% |
+9,089
| New | +$235K |
|
|
SPRB
47
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $125K | 0.01% |
+58,029
| New | +$125K |
|
|
CTIC
48
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-2,794,542
| Closed | -$11.7M |
|
|
KDNY
49
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-1,002,348
| Closed | -$23.2M |
|
50
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-448
| Closed | -$89.7K |
|